Why should we not worry about VARIANTS "escaping" immunity from vaccines or natural infection; why are we not likely to need vaccine BOOSTERS? Remember immunity is both antibody and cell-mediated (CD4 and CD8 cells). Long-term immunity mediated by memory B & T cells (both get
stimulated if they see the virus again). We now feel secure that T-cell immunity will be preserved against variants after these 2 papers reassured us. Sette's great paper showing T-cell immunity after natural infection or mRNA vaccination preserved against biorxiv.org/content/10.110…
B.1.1.7 (UK), B.1.351 (South Africa), P.1 (Brazil), and CAL.20C (California). Means T cells generated by vaccines can readily fight these variants. 2nd paper is by Dr. Redd one showing that CD8 responses preserved despite spike protein mutations academic.oup.com/ofid/advance-a…
in B.1.1.7 (UK), B.1.351 (S. Africa), P.1 (Brazil);Basically, your T cell response is so complicated & varied across the spike protein, a few mutations don't matter. Could be true of antibodies too; we just only measure a few (remember that); T cells assays in labs reveal breadth
I tweeted 3rd paper that showed this back in Feb. This was written at a time UK was worried about vax not working against B.1.1.7 and B.1.351. After vaccine, "the majority of the T cell response was directed against epitopes conserved" across variants. researchsquare.com/article/rs-226…
"However, after single vaccination, which induced only modestly neutralizing homotypic antibody titers neutralization against the variants of concern was completely abrogated in the majority of vaccinees". So, T cells after vax neutralize variants. 4th paper that showed this next
And T cells generated by AZ vaccine: "of 87 spike-specific antigens [T cell epitopes] identified by the sequencing, 75 remained unaffected by the B.1.351 mutations" (South Africa) variants in the South Africa trial nejm.org/doi/full/10.10…
And finally, this large 6-month analysis of the real-world effectiveness of the Pfizer vaccine across multiple settings shows high effectiveness against the B.1.351 (E484K containing, S. Africa) variant. Will we need boosters? Likely not- continue tomorrow pfizer.com/news/press-rel…
But this very famous long-time virologist Dr. Vincent Racaniello was a bit more forceful than I just was when he said- please stop with the variants! thestreet.com/latest-news/th…
Wanted to add to this thread on how vaccines cover variants (see above, T cells) to explain why we are unlikely to need yearly boosters. #1 - vaccines cover variants. As cases come down, less chance virus to mutate; #2- coronavirus doesn't mutate readily nature.com/articles/nrmic…
Coronaviruses actually have a strong "proofreading" mechanism, meaning they don't tolerate mutations and go back and fix them unlike influenza (another RNA virus with a very "leaky" or mutation-prone polymerase or replicating mechanism); #3 - we should have long-lasting immunity
Remember my ode to memory B cells when I cheated on T cells and told you about them. We know that memory B cells generated by these vaccines because these researchers actually biopsied lymph nodes of brave volunteers to prove it! And we know memory B researchsquare.com/article/rs-310…
cells can trigger immune responses DECADES later if see virus again. So, don't think we are going to be needing yearly booster shots for #covid19. And probably need better global flu vaccine too. Hope this thread relieves some tension on variants/boosters nature.com/articles/natur…
HOW LONG DOES IMMUNITY LAST? To COVID vaccines or infection? We do not really know but there have been some really nice papers lately that give us more information. Please remember immunity divided into antibodies (which can come down & not work as well against variants)
IgA is one in the nose & mouth ("mucosa") that is raised by shots (vaccines) to certain extent but rise higher after natural infection; IgG is the one that is "humoral" or in the bloodstream. Many threads on here about cellular-mediated immunity: B & T cells cover all variants
This recent preprint is really important and summarized by @florian_krammer below in depth. Main take-aways: Breakthrough infections induce IgA (we knew) but protection from vaccine long-lasting even against former variants to severe disease/mortality
RSV VACCINE FOR OLDER ADULTS: Respiratory syncytial virus (RSV) respiratory virus (most common after flu pre-COVID). 2 subtypes, A&B (1 dominates/season). Droplet; Recurrent infections. Most severe in neonates & adults >65; FDA approves 1st RSV vax today msn.com/en-us/news/us/…
RSV vaccine 3 trials of new RSV vaccine, all published in the @NEJM recently so just to keep them straight- here is the vaccine which just got approved May 3 by the FDA for older adults. Remember our T/B cells so protection against severe disease higher! nejm.org/doi/full/10.10…
A single dose of the RSVPreF3 OA vaccine had an acceptable safety profile and prevented RSV-related severe respiratory illness by 94% in adults>=60 years (71% against RSV infection, likely to fall with time as antibodies fall but severe disease protection will remain)
NASAL VACCINES: To explain nasal vaccines, we have to explain the immune system first.
IgA is an antibody that helps attack the pathogen and exists in mucosal surfaces (like nose/mouth)
IgG is an antibody that is in the bloodstream bbc.com/news/world-asi…
Cellular immunity is fantastic, redundant (so even if one cell line down in immunocompromised, have other), generated by either vaccine or infection; Comprised of
T cells- so in breadth from vax - works even across spike protein with its mutations
And the 2nd type of cell produced by vaccines or infection -B cell- amazing thing about B cells is that - if see omicron or one of its subvariants in future- they make antibodies adapted to that variant or subvariant (aided by T cells); adaptive immunity
PUBLIC HEALTH POLICY: Seem to be at reckoning phase of COVID response- what worked, what didn't. Which interventions will be used in future pandemic responses? Interventions asked of public need good medical evidence for them (e.g. RCTs preferably, systematic reviews) to impose
In our field, Cochrane reviews represent best way to sum up the medical evidence to date by performing meta-analyses or systemic reviews of currently-available data; here is Cochrane on masks & other interventions for respiratory viruses including COVID cochranelibrary.com/cdsr/doi/10.10…
Many asked past 3 years how CDC developed policies on masks (& age to mask), distancing (feet), ventilation, schools-> all non-pharmaceutical interventions. Originally theory-based. Now 3 years in, have data (RCTs highest level) to form policies from both US and other countries
VACCINE DISCRIMINATION: We need to stop vaccine requirements for US entry like almost every other country. Am finishing COVID chapter for our ID "bible" & vaccines prevented transmission early on with alpha, but not enough now with current variants to justify such discrimination
Moreover, shame, stigma, blame (remember COVIDiots?), coercion, discrimination not good public health tools. When used for HIV, public health & ID physicians decried them but tactics used a lot in COVID. This book tries to explore & correct that for future barnesandnoble.com/w/endemic-moni…
Concept of #harmreduction in pandemic responses means watching carefully if vulnerable people (like students, older people, low-income populations, migrants, sex workers, prisoners, those with disabilities, refugees, minorities) harmed more by response nature.com/articles/s4146…
FEAR: Some media & public health officials concerned Americans aren't fearful of COVID now. But the vaccines & therapeutics DO WORK. If we can't celebrate biomedical advances & imbibe their effectiveness (we have better tools for COVID than flu), what is point of developing?
In HIV medicine, when therapies came out, we didn't say to people- stay fearful; make this the controlling principle of your life. The book #Endemic I wrote (coming out July 11, 2023) hails these biomedical advances & the age we are in to fight pandemics to reassure the world
This is a rather brilliant summary of the issue from @benryanwriter